260 related articles for article (PubMed ID: 24492652)
21. Bile acids modulate colonic MAdCAM-1 expression in a murine model of combined cholestasis and colitis.
Gao RY; Shearn CT; Orlicky DJ; Battista KD; Alexeev EE; Cartwright IM; Lanis JM; Kostelecky RE; Ju C; Colgan SP; Fennimore BP
Mucosal Immunol; 2021 Mar; 14(2):479-490. PubMed ID: 33004979
[TBL] [Abstract][Full Text] [Related]
22. Sweroside ameliorates α-naphthylisothiocyanate-induced cholestatic liver injury in mice by regulating bile acids and suppressing pro-inflammatory responses.
Yang QL; Yang F; Gong JT; Tang XW; Wang GY; Wang ZT; Yang L
Acta Pharmacol Sin; 2016 Sep; 37(9):1218-28. PubMed ID: 27498779
[TBL] [Abstract][Full Text] [Related]
23. Different effects of ursodeoxycholic acid on intrahepatic cholestasis in acute and recovery stages induced by alpha-naphthylisothiocyanate in mice.
Zhang L; Su H; Li Y; Fan Y; Wang Q; Jiang J; Hu Y; Chen G; Tan B; Qiu F
Toxicol Appl Pharmacol; 2018 Mar; 342():69-78. PubMed ID: 29407775
[TBL] [Abstract][Full Text] [Related]
24. Ursodeoxycholate inhibits mast cell activation and reverses biliary injury and fibrosis in Mdr2
Meng F; Kennedy L; Hargrove L; Demieville J; Jones H; Madeka T; Karstens A; Chappell K; Alpini G; Sybenga A; Invernizzi P; Bernuzzi F; DeMorrow S; Francis H
Lab Invest; 2018 Nov; 98(11):1465-1477. PubMed ID: 30143751
[TBL] [Abstract][Full Text] [Related]
25. Artemisia capillaris extract protects against bile duct ligation-induced liver fibrosis in rats.
Han JM; Kim HG; Choi MK; Lee JS; Lee JS; Wang JH; Park HJ; Son SW; Hwang SY; Son CG
Exp Toxicol Pathol; 2013 Sep; 65(6):837-44. PubMed ID: 23298556
[TBL] [Abstract][Full Text] [Related]
26. Tetrahydroxylated bile acids improve cholestatic liver and bile duct injury in the Mdr2
Fuchs CD; Dixon ED; Hendrikx T; Mlitz V; Wahlström A; Ståhlman M; Scharnagl H; Stojakovic T; Binder CJ; Marschall HU; Trauner M
Hepatol Commun; 2022 Sep; 6(9):2368-2378. PubMed ID: 35691019
[TBL] [Abstract][Full Text] [Related]
27. Bile acid abnormalities in cholestatic liver diseases.
Salen G; Batta AK
Gastroenterol Clin North Am; 1999 Mar; 28(1):173-93. PubMed ID: 10198784
[TBL] [Abstract][Full Text] [Related]
28. Long-term effect of treating pregnant rats with ursodeoxycholic acid on the congenital impairment of bile secretion induced in the pups by maternal cholestasis.
Macias RI; Serrano MA; Monte MJ; Jimenez S; Hernandez B; Marin JJ
J Pharmacol Exp Ther; 2005 Feb; 312(2):751-8. PubMed ID: 15452192
[TBL] [Abstract][Full Text] [Related]
29. [Effect of emodin on P-gp expression in intrahepatic cholestatic rats].
Zhou F; Xu H
Zhongguo Zhong Yao Za Zhi; 2010 Apr; 35(7):908-11. PubMed ID: 20575398
[TBL] [Abstract][Full Text] [Related]
30. Ursodeoxycholic acid limits liver histologic alterations and portal hypertension induced by bile duct ligation in the rat.
Poo JL; Feldmann G; Erlinger S; Braillon A; Gaudin C; Dumont M; Lebrec D
Gastroenterology; 1992 May; 102(5):1752-9. PubMed ID: 1568585
[TBL] [Abstract][Full Text] [Related]
31. Inhibition of integrin alphavbeta6 on cholangiocytes blocks transforming growth factor-beta activation and retards biliary fibrosis progression.
Patsenker E; Popov Y; Stickel F; Jonczyk A; Goodman SL; Schuppan D
Gastroenterology; 2008 Aug; 135(2):660-70. PubMed ID: 18538673
[TBL] [Abstract][Full Text] [Related]
32. Effect of ursodeoxycholic acid on bile acid profiles and intestinal detoxification machinery in primary biliary cirrhosis and health.
Dilger K; Hohenester S; Winkler-Budenhofer U; Bastiaansen BA; Schaap FG; Rust C; Beuers U
J Hepatol; 2012 Jul; 57(1):133-40. PubMed ID: 22414767
[TBL] [Abstract][Full Text] [Related]
33. Protective effects of n-Butanol extract and iridoid glycosides of Veronica ciliata Fisch. Against ANIT-induced cholestatic liver injury in mice.
Hua W; Zhang S; Lu Q; Sun Y; Tan S; Chen F; Tang L
J Ethnopharmacol; 2021 Feb; 266():113432. PubMed ID: 33011367
[TBL] [Abstract][Full Text] [Related]
34. The role of ursodeoxycholic acid on cholestatic hepatic fibrosis in infant rats.
Tang N; Zhang Y; Liang Q; Liu Z; Shi Y
Mol Med Rep; 2018 Mar; 17(3):3837-3844. PubMed ID: 29257337
[TBL] [Abstract][Full Text] [Related]
35. Ursodeoxycholic acid administration in patients with cholestasis of pregnancy: effects on primary bile acids in babies and mothers.
Mazzella G; Rizzo N; Azzaroli F; Simoni P; Bovicelli L; Miracolo A; Simonazzi G; Colecchia A; Nigro G; Mwangemi C; Festi D; Roda E
Hepatology; 2001 Mar; 33(3):504-8. PubMed ID: 11230728
[TBL] [Abstract][Full Text] [Related]
36. Influence of cholestasis on absorption of ursodeoxycholic acid.
Sauer P; Benz C; Rudolph G; Klöters-Plachky P; Stremmel W; Stiehl A
Dig Dis Sci; 1999 Apr; 44(4):817-22. PubMed ID: 10219843
[TBL] [Abstract][Full Text] [Related]
37. The choleretic role of tauroursodeoxycholic acid exacerbates alpha-naphthylisothiocyanate induced cholestatic liver injury through the FXR/BSEP pathway.
Zhao J; Song G; Weng F; Li Y; Zou B; Jin J; Yan D; Sun X; Liu C; Qiu FR
J Appl Toxicol; 2023 Jul; 43(7):1095-1103. PubMed ID: 36787806
[TBL] [Abstract][Full Text] [Related]
38. Clinical efficacy and effectiveness of ursodeoxycholic acid in cholestatic liver diseases.
Festi D; Montagnani M; Azzaroli F; Lodato F; Mazzella G; Roda A; Di Biase AR; Roda E; Simoni P; Colecchia A
Curr Clin Pharmacol; 2007 May; 2(2):155-77. PubMed ID: 18690863
[TBL] [Abstract][Full Text] [Related]
39. [Effects of urso-deoxycholic acid (UDCA) on alpha-naphthyl-isothiocyanate (ANIT) induced intrahepatic cholestasis in rats].
Ando M
Nihon Shokakibyo Gakkai Zasshi; 1992 Oct; 89(10):2586-93. PubMed ID: 1404970
[TBL] [Abstract][Full Text] [Related]
40. Loss of A(1) adenosine receptor attenuates alpha-naphthylisothiocyanate-induced cholestatic liver injury in mice.
Yang P; Chen P; Wang T; Zhan Y; Zhou M; Xia L; Cheng R; Guo Y; Zhu L; Zhang J
Toxicol Sci; 2013 Jan; 131(1):128-38. PubMed ID: 22956627
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
